References
- Andersen T. I., Paus E., Nesland J. M., McKenzie S. J., Borresen A. Detection of C-erbB-2 related protein in sera from breast cancer patients: relationship to erbB-2 gene amplification and c-erbB-2 protein overexpression in tumour. Acta Oncologica 1995; 34: 499–504
- Breuer B., DeVivo I., Luo J. C., Smith S., Pincus M. R., Tatum A. H., Daucher J., Minick C. R., Miller D. G., Nowak E. J., Cody H. S., Niman H., Carney W. P., Brandt-Rauf P. W. erbB-2 and myc oncoproteins in sera and tumors of breast cancer patients. Cancer Epidemiology, Biomarkers & Prevention 1994; 3: 63–66
- Carney W. P., Hamer P. J., Petit D., Retos C., Greene R., Zabrecky J. R., McKenzie S., Hayes D., Kufe D., DeLellis R., Naber S., Wolfe H. Detection and quantitation of the human neu oncoprotein. Journal of Tumor Marker Oncology 1991; 6: 53–72
- DeVivo I., Breuer B., Smith S., Milling C., Pincus M., Tatum A. H., Daucher J., Niman H., Minick R., Osborne M., Miller D., Nowak E., Cody H., Brandt-Rauf P. W. Detection of serum c-myc oncoprotein in cancer patients by immunoblot. Medical Science Research 1993; 21: 345–347
- Isola J. J., HolLI K., Oksa H., Teramoto Y., Kallioniemi O. P. Elevated erbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer. Cancer 1994; 73: 652–658
- Kandl H., Seymour L., Bezwooa W. R. Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer. yJournal of Cancer 1994; 70: 739–742
- Kynast B., Binder L., Marx D., Zoll B., Schmoll H. J., Oellerch M., Schauer A. Determination of a fragment of the c-erbB-2 translational product p 185 in serum of breast cancer patients. Cancer Research Clinical Oncology 1993; 119: 249–252
- Leitzel K., Teramoto Y., Samson E. L., Wallingford A., Weaver S., Demers L., Harvey H., Lipton A. Elevated c-erbB-2 levels in the serum and tumor extracts of breast cancer patients. Proceedings of the American Association for Cancer Research 1991; 32: 167
- Leitzel K., Teramoto Y., Konrad K., Chinchilli V. M., Volas G., Grossberg H., Harvey H., Demers L., Lipton A. Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer. Journal of Clinical Oncology 1995; 13: 1129–1135
- Luo J. C., Yu M. W., Chen C. J., Santella R. M., Carney W. P., Brandt-Rauf P. W. Serum c-erbB-2 oncopeptide in hepatocellular carcinogenesis. Medical Science Research 1993; 21: 305–307
- Narita T., Funahashi H., Satoh Y., Takagi H. C-erbB-2 protein in the sera of breast cancer patients. Breast Cancer Research and Treatment 1992; 24: 97–102
- SAS. SAS/STAT user's guide. SAS Instit. Inc, CarY, NC 1990
- Sugano K., Kawai T., Ishii M., Koyamm H., Kitajima M., Kasumi F., Demura R., Nakayama T., Okabe H., Mori S., Ohkura H. Clinical evaluation of serum erbB-2 protein using enzyme immuno assay (ErbB-2 EIA (Nichireil). Gan To Kagaku Ryoho 1994a; 21: 1255–1262
- Sugano K., Kawai T, Ishii M., Koyama H., Kitajima M., Kasum F., Demura R., Nakayama T., Okabe H., Mori S., Ohkura H. Clinical Study of serum erbB-2 protein using sandwich radioimmunometric assay (ErbB-2 IRMA ‘Eiken’). Gan To Kagaku Ryoho 1994b; 21: 1245–1253
- Watanabe N., Miyamoto M., Tokuda Y., Kubota M., Ando Y., Tajima T., Mitomi T. Serum c-erbB-2 in breast cancer patients. Acta Oncologica 1994; 33: 901–904